| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.079 | 7.425 | 547 | 1.052 | 931 | 2.966 | 4.030 | 3.160 | 6.619 | 7.330 |
| Total Income - EUR | 1.079 | 7.649 | 972 | 1.052 | 938 | 2.966 | 4.030 | 3.160 | 6.619 | 7.330 |
| Total Expenses - EUR | 548 | 811 | 49 | 87 | 32 | 27 | 114 | 44 | 99 | 191 |
| Gross Profit/Loss - EUR | 530 | 6.839 | 923 | 965 | 906 | 2.939 | 3.916 | 3.117 | 6.520 | 7.140 |
| Net Profit/Loss - EUR | 498 | 6.660 | 906 | 933 | 878 | 2.850 | 3.795 | 3.022 | 5.477 | 5.997 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Farmadata Total Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 5.637 | 11.830 | 12.537 | 13.242 | 13.878 | 16.527 | 19.966 | 23.015 | 28.878 | 19.971 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 5.261 | 11.649 | 12.421 | 13.053 | 13.681 | 16.392 | 19.263 | 22.991 | 27.038 | 15.309 |
| Cash | 376 | 181 | 117 | 189 | 197 | 135 | 703 | 24 | 1.840 | 4.661 |
| Shareholders Funds | 5.211 | 11.818 | 12.525 | 13.228 | 13.850 | 16.438 | 19.868 | 22.952 | 28.359 | 19.623 |
| Social Capital | 45 | 45 | 44 | 43 | 0 | 0 | 0 | 0 | 40 | 40 |
| Debts | 426 | 12 | 13 | 13 | 28 | 89 | 98 | 63 | 520 | 348 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Farmadata Total Srl